Seretide Diskus 50 mcg / 100 mcg combines salmeterol and fluticasone propionate to support long-term control of respiratory symptoms. It helps maintain open airways while reducing airway inflammation, improving breathing comfort and symptom management.
Seretide Diskus 50 mcg / 250 mcg combines salmeterol and fluticasone propionate to provide long-term respiratory control. It helps keep the airways open while reducing inflammation, supporting improved breathing and symptom prevention
Seretide Diskus 50 mcg / 500 mcg combines salmeterol, a long-acting bronchodilator, with fluticasone propionate, an inhaled corticosteroid, to provide comprehensive respiratory control. This dual-action therapy helps keep the airways open while reducing underlying inflammation, leading to improved breathing and symptom stability. Regular use supports better lung function, lowers the risk of exacerbations, and provides long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Serobid Rotacaps 50 mcg contains salmeterol, a long-acting bronchodilator used to help keep the airways open for easier breathing. It supports long-term control of respiratory symptoms and helps reduce episodes of breathlessness and wheezing. Commonly prescribed for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Seroflo Inhaler 125 is a combination inhalation therapy containing fluticasone propionate and salmeterol, designed to provide both anti-inflammatory and bronchodilator benefits. It helps control airway swelling, prevent breathing difficulties, and maintain smoother airflow throughout the day. Regular use supports better symptom management, reduces the risk of asthma exacerbations, and promotes long-term respiratory stability in patients with asthma and COPD.
Seroflo Inhaler 50 is a combination respiratory therapy containing fluticasone propionate and salmeterol, formulated to provide ongoing control of airway inflammation and bronchoconstriction. It helps maintain open airways, improve breathing capacity, and reduce the frequency of respiratory symptoms. Regular use supports effective long-term management of asthma and chronic obstructive pulmonary disease (COPD).
Tiova Inhaler contains tiotropium bromide, a long-acting bronchodilator designed to provide sustained airway relaxation and improved breathing function. It helps keep the airways open for extended periods, reducing symptoms such as breathlessness, wheezing, and chest tightness. Commonly used as maintenance therapy, it supports long-term symptom control and improved quality of life in patients